Heron Gross Profit from 2010 to 2025

HRTX Stock  USD 2.38  0.02  0.83%   
Heron Therapeuti Gross Profit yearly trend continues to be fairly stable with very little volatility. Gross Profit is likely to outpace its year average in 2025. Gross Profit is the profit Heron Therapeuti makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals
 
Gross Profit  
First Reported
1987-03-31
Previous Quarter
23.4 M
Current Value
30.6 M
Quarterly Volatility
8.8 M
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Heron Therapeuti financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Heron Therapeuti's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.6 M, Interest Expense of 6.3 M or Total Revenue of 151.5 M, as well as many indicators such as Price To Sales Ratio of 1.54, Dividend Yield of 0.0 or Days Sales Outstanding of 112. Heron financial statements analysis is a perfect complement when working with Heron Therapeuti Valuation or Volatility modules.
  
Check out the analysis of Heron Therapeuti Correlation against competitors.
For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.

Latest Heron Therapeuti's Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Heron Therapeuti over the last few years. Gross profit is a required income statement account that reflects total revenue of Heron Therapeuti minus its cost of goods sold. It is profit before Heron Therapeuti operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Heron Therapeuti's Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Heron Therapeuti's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 88.95 M10 Years Trend
Slightly volatile
   Gross Profit   
       Timeline  

Heron Gross Profit Regression Statistics

Arithmetic Mean27,513,491
Geometric Mean19,848,567
Coefficient Of Variation188.53
Mean Deviation42,283,741
Median40,325,000
Standard Deviation51,870,023
Sample Variance2690.5T
Range172.1M
R-Value0.80
Mean Square Error1018.4T
R-Squared0.65
Significance0.0002
Slope8,761,579
Total Sum of Squares40357.5T

Heron Gross Profit History

2025110.9 M
2024105.6 M
202361.9 M
202252.8 M
202140.3 M
202052.4 M
201984.3 M

Other Fundumenentals of Heron Therapeuti

Heron Therapeuti Gross Profit component correlations

0.740.09-0.630.690.491.00.390.36-0.040.870.60.70.80.760.320.820.820.830.25
0.74-0.550.050.1-0.230.780.320.14-0.220.86-0.080.170.990.130.080.320.910.91-0.4
0.09-0.55-0.740.620.840.03-0.320.110.31-0.090.770.52-0.470.64-0.050.39-0.24-0.220.86
-0.630.05-0.74-0.89-0.97-0.57-0.2-0.28-0.2-0.27-0.97-0.83-0.04-0.97-0.33-0.85-0.14-0.16-0.86
0.690.10.62-0.890.870.670.290.570.210.410.860.870.210.920.450.860.280.310.75
0.49-0.230.84-0.970.870.430.150.330.220.140.960.8-0.140.920.350.770.00.020.88
1.00.780.03-0.570.670.430.410.4-0.060.890.540.670.830.710.320.790.850.860.2
0.390.32-0.32-0.20.290.150.410.53-0.170.140.070.420.320.250.930.510.140.13-0.08
0.360.140.11-0.280.570.330.40.53-0.060.250.20.470.190.340.660.440.160.20.12
-0.04-0.220.31-0.20.210.22-0.06-0.17-0.06-0.120.230.25-0.180.15-0.050.11-0.11-0.10.33
0.870.86-0.09-0.270.410.140.890.140.25-0.120.260.430.90.430.010.510.960.97-0.04
0.6-0.080.77-0.970.860.960.540.070.20.230.260.80.020.960.220.80.160.170.84
0.70.170.52-0.830.870.80.670.420.470.250.430.80.250.860.520.870.350.360.6
0.80.99-0.47-0.040.21-0.140.830.320.19-0.180.90.020.250.230.10.40.930.93-0.29
0.760.130.64-0.970.920.920.710.250.340.150.430.960.860.230.350.890.320.340.76
0.320.08-0.05-0.330.450.350.320.930.66-0.050.010.220.520.10.350.56-0.03-0.030.15
0.820.320.39-0.850.860.770.790.510.440.110.510.80.870.40.890.560.410.420.61
0.820.91-0.24-0.140.280.00.850.140.16-0.110.960.160.350.930.32-0.030.411.0-0.2
0.830.91-0.22-0.160.310.020.860.130.2-0.10.970.170.360.930.34-0.030.421.0-0.18
0.25-0.40.86-0.860.750.880.2-0.080.120.33-0.040.840.6-0.290.760.150.61-0.2-0.18
Click cells to compare fundamentals

About Heron Therapeuti Financial Statements

Heron Therapeuti investors use historical fundamental indicators, such as Heron Therapeuti's Gross Profit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Heron Therapeuti. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Gross Profit105.6 M110.9 M
Gross Profit Margin 0.73  0.52 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Heron Stock Analysis

When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.